ReWalk Restore
FDA 510(k) K190337 · Re Walk Robotics , Ltd.
510(k) numberK190337
Submission
- Device name
- ReWalk Restore
- Applicant
- Re Walk Robotics , Ltd.
Yokneam, IL - Received
- February 14, 2019
- Decision date
- June 3, 2019
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- PHL – Powered Exoskeleton
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 890.3480
- Specialty
- Physical Medicine
A powered exoskeleton is a prescription device that is composed of an external, powered, motorized orthosis that is placed over a person's paralyzed or weakened lower extremity limb(s) for medical purposes.
Other 510(k)s with product code PHL
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K254198 | Trexo TheoPHL · Traditional | Trexo Robotics, Inc. | 09/02/2026SE |
| K260381 | EvePHL · Traditional | Wandercraft SAS | 08/03/2026SE |
| K250904 | Atalante XPHL · Traditional | Wandercraft SAS | 10/24/2025SE |
| K241822 | ReWalk® 7 Personal Exoskeleton (50-20-0005)PHL · Traditional | Rewalk Robotics Ltd. Dba Lifeward | 03/12/2025SE |
| K233695 | Medical HAL Lower Limb Type (HAL-ML)PHL · Traditional | Cyberdyne, Inc. | 05/07/2024SE |
| K232077 | Atalante XPHL · Traditional | Wandercraft SAS | 12/13/2023SE |
| K221696 | ReWalk P6.0PHL · Traditional | Re Walk Robotics , Ltd. | 03/02/2023SE |
| K221859 | AtalantePHL · Traditional | Wandercraft SAS | 12/29/2022SE |
| K220988 | EksoNRPHL · Traditional | Ekso Bionics, Inc. | 06/09/2022SE |
| K213452 | Gems-HPHL · Traditional | Samsung Electronics Co., Ltd. | 04/21/2022SE |
More from Samsung Electronics Co., Ltd.
Questions and answers
When was ReWalk Restore cleared by the FDA?
ReWalk Restore (K190337) received a 510(k) decision of Substantially Equivalent on June 3, 2019, 109 days after the submission was received.
What is the product code of K190337?
The FDA product code is PHL – Powered Exoskeleton, a Class II (moderate risk) device regulated under 21 CFR 890.3480.